October 27, 2026 · The Nurse practitioner · DOI: 10.1097/01.NPR.0000000000000490

Biologic therapy: A paradigm shift in asthma management.

Listen to this summary

This review gives primary care nurse practitioners an overview of how Type 2 inflammation drives asthma, how the biologics approved for asthma work, and what to monitor and consider in practice. The central question is how these targeted therapies can improve health, safety, quality of life, and long-term outcomes for patients with moderate-to-severe uncontrolled asthma. Note that the publication date listed (2026) is later than the current date would typically allow, so the details should be verified against the original article.

Mara Thrasher

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

“

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play